| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.001 |